InvestorsHub Logo
Followers 0
Posts 4035
Boards Moderated 0
Alias Born 10/31/2017

Re: BullsOnFire post# 13411

Friday, 05/18/2018 12:38:04 PM

Friday, May 18, 2018 12:38:04 PM

Post# of 18666
OXS-3550 for liquid tumors. The TRiKE platform has shown promising in vivo data compared to BiKEs. (The addition of Il-15 created NK cell proliferation resulting in 60-70% remission vs 30-50% for BiKE)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTBP News